Spineway (ALSPW) - Total Assets
Based on the latest financial reports, Spineway (ALSPW) holds total assets worth €30.20 Million EUR (≈ $35.31 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Spineway for net asset value and shareholders' equity analysis.
Spineway - Total Assets Trend (2009–2024)
This chart illustrates how Spineway's total assets have evolved over time, based on quarterly financial data.
Spineway - Asset Composition Analysis
Current Asset Composition (December 2024)
Spineway's total assets of €30.20 Million consist of 45.7% current assets and 54.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 14.9% |
| Accounts Receivable | €3.30 Million | 10.9% |
| Inventory | €4.73 Million | 15.6% |
| Property, Plant & Equipment | €2.53 Million | 8.3% |
| Intangible Assets | €3.61 Million | 11.9% |
| Goodwill | €5.90 Million | 19.4% |
Asset Composition Trend (2009–2024)
This chart illustrates how Spineway's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Spineway worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Spineway's current assets represent 45.7% of total assets in 2024, an increase from 0.0% in 2009.
- Cash Position: Cash and equivalents constituted 14.9% of total assets in 2024, up from 1.4% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 0.0% in 2009.
- Asset Diversification: The largest asset category is goodwill at 19.4% of total assets.
Spineway Competitors by Total Assets
Key competitors of Spineway based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SKAN Group AG
SW:SKAN
|
Switzerland | CHF381.49 Million |
|
Hubei Huaqiang High-Tech Co. Ltd. A
SHG:688151
|
China | CN¥4.82 Billion |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Spineway - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.34 | 2.34 | 1.29 |
| Quick Ratio | 1.50 | 1.29 | 0.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €7.68 Million | €6.83 Million | €1.46 Million |
Spineway - Advanced Valuation Insights
This section examines the relationship between Spineway's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.27 |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | 15.6% |
| Total Assets | €30.41 Million |
| Market Capitalization | $6.22 Million USD |
Valuation Analysis
Below Book Valuation: The market values Spineway's assets below their book value (0.20x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Spineway's assets grew by 15.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Spineway (2009–2024)
The table below shows the annual total assets of Spineway from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €30.41 Million ≈ $35.55 Million |
+15.57% |
| 2023-12-31 | €26.31 Million ≈ $30.76 Million |
-5.00% |
| 2022-12-31 | €27.70 Million ≈ $32.38 Million |
+8.32% |
| 2021-12-31 | €25.57 Million ≈ $29.89 Million |
+73.37% |
| 2020-12-31 | €14.75 Million ≈ $17.24 Million |
+15.45% |
| 2019-12-31 | €12.77 Million ≈ $14.93 Million |
+71.90% |
| 2018-12-31 | €7.43 Million ≈ $8.69 Million |
-25.03% |
| 2017-12-31 | €9.91 Million ≈ $11.59 Million |
+4.89% |
| 2016-12-31 | €9.45 Million ≈ $11.05 Million |
+5.45% |
| 2015-12-31 | €8.96 Million ≈ $10.48 Million |
-20.27% |
| 2014-12-31 | €11.24 Million ≈ $13.14 Million |
+20.80% |
| 2013-12-31 | €9.31 Million ≈ $10.88 Million |
+89.55% |
| 2012-12-31 | €4.91 Million ≈ $5.74 Million |
+31.09% |
| 2011-12-31 | €3.74 Million ≈ $4.38 Million |
+50.15% |
| 2010-12-31 | €2.49 Million ≈ $2.92 Million |
+21.13% |
| 2009-12-31 | €2.06 Million ≈ $2.41 Million |
-- |
About Spineway
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The comp… Read more